1. Medtech Insight
  2. >>Archive

Loctite's Indermil skin adhesive kits launched in UK

Loctite's Indermil skin adhesive kits have been launched in the UK. The Hertfordshire-based company has produced two kits, for surgical and clinical use kit, both of which are on a one-year commercial trial before full European launch. The clinical kit is a hand-held dispenser for paramedical, military and emergency use. The surgical kit consists of a control box with a touch pad peristaltic foot pump and two-metre delivery cable with a pen-like precision applicator.

Loctite's Indermil skin adhesive kits have been launched in the UK. The Hertfordshire-based company has produced two kits, for surgical and clinical use kit, both of which are on a one-year commercial trial before full European launch. The clinical kit is a hand-held dispenser for paramedical, military and emergency use. The surgical kit consists of a control box with a touch pad peristaltic foot pump and two-metre delivery cable with a pen-like precision applicator.

UK sales of 2,000 units of the clinical kit and 20-50 units of the surgical kit are targeted for this year, selling for £16 ($24) and £3,000 respectively, anticipates Heinrich...

More from Archive

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.